1Chronic Leukemia Myeloma Task Force d the National Cancer Institute.Proposed guideline for protocol studies.II.Plasma cell myeloma.Cancer Chemother Rep, 1973, 4: 145-158.
2Blade J, Ferbandez-Llama P, Bosch F, et al. Renal failure in multiple myeloma:presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med, 1998, 158: 1889-1893.
3Knudsen LM, HjoRh M, Hippe E. Renal failure in multiple myeloma:reversibility and impact on the prognosis. Eur J Haematol, 2000, 65:175-181.
4Alexianian R, Barlogie B, Dixon D. Renal failure in multiple myeloma.Pathogenesis and prognostic implications .Arch Intern Med,1990, 150:1693-1695.
5Knudsen LM, Hippe E, Hjorth M, et al. Renal failure in newly diagnosed multiple myeloma — a demographic syudy of 1353 patients. Eur J Haematol,1994, 53: 207-212.
6Misiani R, Tiraboschi G, Minganti G, et al. Management of mydoma kidney: an anti-light-chain approach. Am J Kidney Dis, 1987, 10: 28-33.
6Blade J,Fernandez-Llama P,Boseh F,et al.Renal failure in multiple myeloma:presenting features and predictors of outoome in 94 patients from a single institution[J].Arch Intern Med, 1998,158 (17):1889-1893.
